Title: OTL tech notes
Full Citation
Permanent Link: http://ufdc.ufl.edu/UF00073864/00010
 Material Information
Title: OTL tech notes
Series Title: OTL tech notes
Physical Description: Serial
Language: English
Creator: Office of Technology Licensing
Publisher: Office of Technology Licensing, Office of Research and Graduate Programs, University of Florida
Publication Date: Summer 2007
 Record Information
Bibliographic ID: UF00073864
Volume ID: VID00010
Source Institution: University of Florida
Rights Management: All rights reserved by the source institution and holding location.


This item has the following downloads:

00001 ( PDF )

Full Text


A publication of the University of Florida Office of Technology Licensing
Summer 2007

The University of Florida is the top-performing public institution at transferring its
research to the marketplace, according to a major new study by the prestigious Milken
Institute. In a report by the California-based economic think tank titled "Mind to Market: A
Global Analysis of University Biotechnology Transfer and Commercialization," UF ranked
fifth overall on the institute's University Technology Transfer and Commercialization Index.
The top four are Massachusetts Institute of Technology (MIT), University of California
System, California Institute of Technology, and Stanford University.
Milken Institute researchers sought to discover which universities do the best job
at technology transfer and commercialization. They compared university technology
transfer processes around the world; studied the common characteristics to successful
commercialization; and measured the role of the university offices of technology transfer.
David Day, director of UF's Office of Technology Licensing, said that UF made a
commitment about six years ago to expand its commercialization efforts. "Now we have
the people and resources necessary to identify promising technologies, pursue patents and
negotiate fair licenses," Day said. "We've also worked hard to nurture our startups so they can
develop their products and become financially successful."
Win Phillips, UF's vice president for research, said that the university's sheer size and
breadth allow it to pursue a wide range of research. UF received nearly $519 million in
research funding in 2006, more than half of it for biomedical research. During the 2005-06
fiscal year, UF earned nearly 43 million in licensing income and ten new companies were
launched based on UF technologies. U

A Celebration of Innovation

The University of Florida's
Office of Technology Licensing
in conjunction with the UF
Foundation recently showcased
a number of UF's later stage
technologies and early stage
startups at the Celebration of
Innovation, March 1st-2nd
at the Hilton University of Florida Hotel and Conference Center. This unique opportunity
enabled investors, entrepreneurs, and potential licensees to see the latest in cutting-edge
technologies working their way from UF laboratories to the marketplace- many in
conjunction with spin-off companies formed specifically to commercialize these discoveries.
As a result of the networking connections that were developed during the Technology
Showcase, UF late-stage technologies and early stage companies are taking the next step in
bringing their technologies to market. U

www.o -ed


UF Tech Connect
An EDA University Center
UF's/EDA University Center's New Name
The University of Florida EDA University Center was
created as a partnership between the University of Florida
and the Economic Development Administration to provide
a venue for bringing together the necessary elements to
create companies. The center recently adopted a new name,
UF Tech Connect TM, to project more clearly the activities
associated with this center.
Supported by the university's Office of Technology
Licensing, this partnership helps Florida universities
accomplish one of their key goals: taking research from the
benchtop to the marketplace. It also helps EDA accomplish
its mission: creating jobs and generating private investment
to help the economy.
The UF Tech Connect TM collaborates with many
public and private organizations to foster new business
creation. The Center develops new programs, sponsors
events, and facilitates mutually beneficial connections.
Housed in and supported by the university's Office of
Technology Licensing, UF Tech Connect TM is at the pulse-
point of the region's high-tech start-up activity. Because of
the tremendous volume of research generated at UF and
the user-friendly reputation of its Office of Technology
Licensing, UF Tech Connect TM serves as a magnet for
entrepreneurs and investors seeking new opportunities, and
a catalyst for new business creation. 0

Entrepreneurship for Scientists & Engineers
University of Florida Tech Connect TM and the UF
Office of Technology Licensing sponsored a four week
seminar series, Entrepreneurship for Scientists and Engi-
neers, in the month of January designed to introduce the
key elements necessary to starting a company for purposes
of getting discoveries to the marketplace.
Speakers included David Day, of the UF Office of
Technology Licensing, Jamie Grooms of Axogen, Inc., Sue
Washer of Applied Genetic Technologies Corporation, Erik
Sander of V2R Group and Dan Rua of Inflexion Partners.
Seminar topics ranged from Intellectual Property and
Entrepreneurship, Preparing Effective Business Plans, and
Business Structures, and Raising Capital. Members of the
audience included CEO's, UF faculty, investors, and indus-
try professionals. The forums were not only informational,
but were an excellent networking opportunity. Through this
seminar series participants were able to understand the "Mind
to Market" process. U

Securities Law: Do's and Don'ts for Start-ups
As part of an on-going Entrepreneur Roundtable
series, the UF Commercialization Council and UF Tech
Connect TM sponsored experts from Research Triangle who
spoke on the Do's and Don'ts for Start-up Companies
Seeking Investments" The speakers, Fred Hutchison of
Hutchison & Mason PLLC and Tim Gupton of Research
Triangle Ventures, spoke to the well-attended forum January
18th at GTEC with the nuts and bolts and possible pitfalls
of raising capital for start-up companies.
Fred Hutchison, the founding president of the Council
for Entrepreneurial Development, has represented more
than 200 entrepreneurial and leading Triangle companies.
"When you start a business, you can't worry about, 'can
I do it?' or 'do I have the money?"' Hutchison said. "The
ones that succeed, it's because of their perseverance."
Tim Gupton, with over 30 years of public accounting
and financial consulting, is the co-founder, start-up chief
financial officer for Alphacax, Inc., a pharmaceutical vaccine
company located in the Research Triangle area. Hutchison
and Gupton gave practical financial and legal advice from
securities to audits and taxes to the enthusiastic crowd.
For information about future entrepreneur roundtables
and networking opportunities, contact Chris Brown, UF
EDA Coordinator, at cbrownll@rgp.ufl.edu or at (352)
392-8929. 0

CEO's of two UF start-ups were recently the guest
speakers at monthly luncheons of the Gainesville Area
Innovation Network. CEO, Ryan Kern, spoke about Sabine
Neurotechnology, Inc, which is a biomedical company
focused on developing innovative products to improve the
speed, accuracy, and safety of Deep Brain Stimulation (DBS)
surgery. Surgeons use DBS to relieve patients suffering from
disabling movement disorders including Parkinson's disease
and dystonia.
Bryan da Frota, Co-founder and CEO for Prioria Inc.
spoke on his company, which develops intelligent embedded
systems. Embedded processing systems are small computers
and sensors physically incorporated into a product to allow
it to receive and analyze information, essentially making
the product "smart." The company's lead product is called
Maveric TM which stands for Micro Air Vehicle Enabling
Reconnaissance, Intelligence and Communication.
GAIN's mission is to encourage technology enterprises
to start up and develop in the Gainesville area by providing
them with support through networking and educational
opportunities. For more information go to http://www.
gain-net.org. f



Oragenics, Inc.
Oragenics, Inc. (AMEX:ONI), a biopharmaceutical
company with a portfolio of proprietary technologies
has announced that, as a result of the positive data from
the clinical trial for its ground-breaking oral probiotic
mouthrinse, it was advising a number of consultancy
groups to submit plans for the sale or license of this
technology. This action will allow Oragenics to focus
on its other lead products currently under development,
especially its new antibiotic, MU1140TM, which has the
potential to make a significant impact on the global anti-
infectives market.
Dr. Raman Bedi, the former Chief Dental Officer
for England and chairman of Oragenics' Scientific
Advisory Committee, stated, "Probiora3TM is set to
transform the multi-billion dollar worldwide anti-
bacterial mouthwash market. The oral probiotic
represents a breakthrough approach to maintaining
oral health by utilizing cultures of bacteria commonly
found in healthy mouths to provide a natural defense
against those bacteria thought to be harmful to teeth
and gums."
Dr. Robert Zahradnik, Oragenics' president and
CEO, added, "Our clinically-supported probiotic-
based approach to maintaining oral health appears to
have a promising future. Probiora3's patent-pending
blend of beneficial micro-organisms can be added
to such products as mouthwashes and toothpastes,
chewing gum, breath mints/lozenges, and quick-dis-
solve strips. The early licensing of this technology
will allow partners) in the oral care and/or food and
nutritional supplement industries to take this inven-
tion to market by the second half of 2007." 0

Florida Biologix
State workforce, education and industry officials
recently unveiled a University of Florida biotechnology
training program in Alachua funded largely by a 7.6. rr 1
state grant. UF's Center of Excellence for Regenerative
Health Biotechnology at the Progress Corporate Park in
Alachua will train current employees or those interested in
working in Florida's biotechnology sector.
Program coordinators met with two biotechnology
focus groups of biotech companies and have conjugated
a needs assessment to see what kind of skills and train-
ing their employees need, such as how to develop new
products and manufacture and test products for humans
in a regulated industry. A series of two-week certificate-
granting courses will start in May, said center director
Richard Snyder.
Workforce Florida, a state employment agency, pro-
vided the grant to fund the Employ Florida Banner Center
for Biotechnology at the Center of Excellence. It is the
third Banner Center in the state focused on training for
high-tech, high-wage jobs as part of former GovernorJeb
Bush's initiative to diversify the state's economy away from
a reliance on tourism.
The Center of Excellence is also home to a state-of-
the-art biomanufacturing facility. "Florida Biologix,
which provides new high-tech jobs right here in Alachua
County and throughout the state" said Director, Richard
Snyder. "Through its drug development services opera-
tion, Florida Biologix fosters translational research,
which in turn helps establish new companies, and helps
existing start-ups mature, creating more jobs." 0



University of Florida
308 Walker Hall
Gainesville, FL 32611-5500

0 ww~tlul6d

Opportunities for Entrepreneurial UF Faculty

APRIL 2007
12: GAIN Lecture-Company Theft
* Gainesville Technology Enterprise Center 11a.m.-1p.m.
* RSVP to Linda Garcia at GarciaLinda@cox.net

20: SBIR Workshop
* McKnight Brain Institute
* RSVP to Chris Brown @ cbrown11@rgp.ufl.edu

24-25: CED' S 24th Annual Venture 207 Conference
* Washington Duke Inn & Golf Club, Durhm, NC
* www.cednc.org/venture

25: GAIN Luncheon
* Gainesville Country Club
* RSVP to Linda Garcia at GarciaLinda@cox.net

30: GAIN Luncheon
* Gainesville Country Club
* RSVP to Linda Garcia at GarciaLinda@cox.net

2007 University of Florida OTL TECHnotes is a quarterly newsletter aimed at
informing and educating University of Florida faculty about Intellectual Property and
OTL commercialization activities To be added to the making list contact Lorraine Phillips,
newsletter Editor, at phillm2@ufl edu For permission to reprint any part of this pubhcation,
contact the Editor

MAY 2007
15: 4th Annual Celebration of BioTechnology
* Regeneration Technologies, Inc. -Alachua, FI
* RSVP, e-mail: shester@biotech.ufl.edu

29-30: 4th Annual Florida Tech Transfer Conference
* The Doral Golf Resort & Spa, Miami, Fl.
* www.floridaresearch.org

UF Office of Technology Licensing
Director: David Day dlday@ufl.edu
Associate Director: Jane Muirjmuir@ufl.edu
Assistant Directors:
Biomedical Sciences
Elizabeth Garami egarami@ufl.edu
Anita Rao arao@ufl.edu
Life Sciences
John Byatt jbyatt@ufl.edu
Engineering & Physical Sciences
Bruce Clary bclary@ufl.edu
Karl Zawoy kzawoy@ufl.edu
Physical Sciences
Lenny Terry Iterry@ufl.edu


University of Florida Home Page
© 2004 - 2010 University of Florida George A. Smathers Libraries.
All rights reserved.

Acceptable Use, Copyright, and Disclaimer Statement
Last updated October 10, 2010 - - mvs